Biotech Firm Sued Over Brain Cancer Vaccine Claim

A biotechnology company whose shares more than doubled after it said that it had obtained regulatory clearance for the world’s first brain cancer vaccine is facing a class action lawsuit in the United States alleging that it misled investors.
Times Online